Health / Health News

    Nanomaterial could enhance diabetes treatment

    Conventional treatments for diabetes can increase the risk of neurological problems, an under-researched side effect. Scientists based at The Ohio State University developed a nanomaterial that binds insulin to a group of amino acids that includes antioxidants.



    Normal blood sugar (white crystals) absorption (left) Vs. insulin resistance in type 2 diabetes (right). Photo: Manu5/Wikimedia Commons


    The nanomaterial improved glucose consumption, leading to better brain function. When compared to mice treated with insulin alone, mice treated with the nanomaterial had improved glucose control and cognition outcomes.

    "We found in mice that our molecule and insulin combined was better than each treatment alone in reversing diabetes-related problems, and produced dramatically improved cognitive performance compared to all other groups," said Ouliana Ziouzenkova, senior author of the study.

    The beneficial results could be caused by the nanomaterials' effect on how the body metabolizes glucose.

    "Our concept provided a balanced metabolic effect involving a unique pathway that is induced by this supramolecular complex," Ziouzenkova noted.

    The amino acid-based nanomaterial could be adapted for other neurological and metabolic disorders. (National Science Foundation)

    MAY 25, 2022



    YOU MAY ALSO LIKE

    NIH findings could lead to ways to combat future SARS-CoV-2 variants.
    Organ-on-a-chip model could result in new treatment options.
    Structural findings could result in more effective, less toxic treatments.
    Seven hours is the ideal amount of sleep for people in their middle age and upwards, with too little (...)
    Complex web of disease transmission in pre-colonial South America.
    Diseases have undergone 'spillback' from humans to wild animals.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact